Neurology 1992-11-01

Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group.

P A LeWitt, M P Galloway, W Matson, P Milbury, M McDermott, D K Srivastava, D Oakes

Index: Neurology 42(11) , 2111-7, (1992)

Full Text: HTML

Abstract

We used two analytic methods (a multichannel coulometric electrode array with high-performance liquid chromatography, and gas chromatography-mass spectrophotometry) to measure CSF dopamine (DA) and its metabolites in mildly affected, unmedicated subjects with Parkinson's disease (PD). The mean (+/- SD) concentration of homovanillic acid (HVA), the most abundant product of DA turnover, was 164.57 +/- 95.05 nM. As sequential aliquots of CSF were collected from the first to 23rd ml, CSF HVA concentration almost doubled. After HVA, 3-O-methyldopa (3-O-MD) was the next most abundant compound. The summed concentrations of 3-O-MD, 3,4-dihydroxyphenylacetic acid, 3-methoxytyramine, DA, DA-3-sulfate, homovanillol, and levodopa (LD) amounted to 12.6% of HVA. Concentrations of the DA metabolites did not correlate to a variety of indices of PD severity. The presence of LD and 3-O-MD may be indicators of DA synthesis and possibly could reflect compensatory processes among surviving dopaminergic neurons of the PD brain.

Related Compounds

Structure Name/CAS No. Articles
Magnesium Structure Magnesium
CAS:7439-95-4
Zinc Structure Zinc
CAS:7440-66-6
Calcium Structure Calcium
CAS:7440-70-2
Strontium Structure Strontium
CAS:7440-24-6
Taurine Structure Taurine
CAS:107-35-7
Aluminum Powder Structure Aluminum Powder
CAS:7429-90-5
mercury(II) cation Structure mercury(II) cation
CAS:7439-97-6
tin Structure tin
CAS:7440-31-5
chromium Structure chromium
CAS:7440-47-3
L-Cystine Structure L-Cystine
CAS:56-89-3